Your browser doesn't support javascript.
loading
Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma.
J Med Chem ; 62(17): 7769-7787, 2019 09 12.
Article in En | MEDLINE | ID: mdl-31415176

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Asthma / Anti-Asthmatic Agents / Enzyme Inhibitors / Drug Discovery / Glutathione Transferase Type of study: Prognostic_studies Language: En Journal: J Med Chem Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Asthma / Anti-Asthmatic Agents / Enzyme Inhibitors / Drug Discovery / Glutathione Transferase Type of study: Prognostic_studies Language: En Journal: J Med Chem Year: 2019 Type: Article